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Granulomas represent a spectrum of inflammatory sequestration responses that may
be initiated by a variety of agents, including non-infectious environmental factors and
infectious microbial pathogens. Although this reaction is designed to be protective,
the associated tissue injury is often responsible for a profound degree of pathology.
While many of the mechanisms that sustain the development of the granuloma are
enigmatic, it is accepted that the maintenance of this inflammatory process is dependent
upon dynamic interactions between an inciting agent, inflammatory mediators, various
immune and inflammatory cells, and structural cells of the involved tissue. The best
studied of the host-dependent processes during granuloma development is the innate
and adaptive immune response. The innate immune response by antigen-presenting
cells [APCs; dendritic cells (DCs) and macrophages] is initiated quickly to protect from
overwhelming pathogens, but with time, can also activate the adaptive immune response.
APCs, essential regulators of the innate immune response, can respond to microbial
ligands through Toll-like receptors (TLRs), which function in the recognition of microbial
components and play an important role to link the innate and adaptive immune responses.
CD4+ T helper (Th) cells are essential regulators of adaptive immune responses and
inflammatory diseases. Recently, the Notch system has been shown to be an important
bridge between APCs and T cell communication circuits. In the present review, we
discuss recent findings that explore the mechanisms in the linkage of innate and adaptive
immunity, including granulomatous formation though TLRs and Notch activation.
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INTRODUCTION
The granulomatous response is a complex host defense mech-
anism that has evolved to provide containment of infectious
and/or environmental agents (Warren, 1976; El-Zammar and
Katzenstein, 2007). The maintenance of this inflammatory pro-
cess is dependent upon an inciting agent and the dynamic
interactions amongst inflammatory mediators, various immune
and inflammatory cells, and structural cells of the involved
tissue (Chensue et al., 1994; Ulrichs and Kaufmann, 2006;
Ramakrishnan, 2012). The best studied of the host-dependent
processes during granuloma development are the innate and
adaptive immune responses, which are characterized by specific
immune cell populations each expressing a defining phenotype
(Chiu et al., 2004; Raymond et al., 2007; Wolf et al., 2007; Carson
et al., 2011).
The initial response to infection is the engagement of the
host’s innate immune system that triggers a rapid, multifaceted
anti-infectious response involving the release of proinflamma-
tory cytokines and eventually leads to the activation of the
adaptive immune response (Kumar et al., 2009). The first line
of defense is initiated when cellular pattern recognition recep-
tors (PRRs) located on antigen-presenting cells (APCs) recognize
pathogen-associated molecular patterns (PAMPs) (Guillot et al.,
2005; Goodman et al., 2010). Recognition of PAMPs by PRRs
rapidly triggers the innate immune response characterized by
an array of antimicrobial immune responses through the induc-
tion of various inflammatory cytokines and chemokines (Kumar
et al., 2009, 2011). Several families of PRRs, including Toll-like
receptors (TLRs), Retonoic acid-inducible gene I (RIG-I)-like
receptors, nucleotide-binding oligomerization-like receptors, and
DNA receptors (cytosolic sensors for DNA) are known to play a
crucial role in host defense (Kumar et al., 2009, 2011). Dendritic
cells (DCs) and macrophages are professional APCs that can
respond to pathogens through PRRs, which function in the recog-
nition of infectious components and play an important role in
both the innate and adaptive immune responses (Akira et al.,
2006; Trinchieri and Sher, 2007). Over time APCs can activate
the adaptive immune response to the invading pathogens by trig-
gering T cell differentiation (Lukacs et al., 2008; Cuddapah et al.,
2010). Recent data have indicated that the controlled expression
of Notch receptor proteins on T cells is essential for normal T cell
development and maturation (Osborne and Minter, 2007). The
connection between PRRs and Notch pathways has helped to
define the complex role of APCs in the regulation of T cell differ-
entiation (Amsen et al., 2009b). We here review recent advances
concerning the role of Notch signaling in T cell differentiation
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during infection and present our findings showing the role of
the Notch system in linking innate and acquired immunity in
inflammatory granulomatous response models.
TYPE-1 AND TYPE-2 GRANULOMA MODELS IN MICE
Data derived from a variety of models demonstrate that a num-
ber of inflammatory systems are involved in the induction of
cytokines, which subsequently play a role in the initiation and
maintenance of chronic experimental pulmonary inflammation
(Raymond et al., 2007). However, the mechanistic contribution
of various cytokines during the evolution, and more impor-
tantly, the maintenance of disease chronicity only recently have
been addressed. For example, in vivo studies assessing the type-1
response elicited during the development of chronic lung granu-
lomas induced by mycobacterial antigen have demonstrated that
Interferon (IFN)-γ, Interleukin (IL)-12, and tumor necrosis fac-
tor (TNF) were necessary for lung lesion progression (Chensue
et al., 1994). In contrast, type-2 experimental chronic lung gran-
ulomas initiated by complex antigens, including those derived
from allergens (e.g., ovalbumin) and parasites (e.g., Schistosoma
mansoni), were shown to be maintained by IL-4, IL-5, and IL-13,
hallmarks of a type 2 response (Chensue et al., 1992; Ruth
et al., 2000; Joshi et al., 2008). One of the most widespread and
well-characterized type-1 granuloma diseases is tuberculosis. It
has been estimated that one-third of the world’s population is
infected withMycobacterium tuberculosis—resulting inmore than
8.8 million cases of active tuberculosis with 1.4 million deaths
globally in 2010 alone. We have established clinically relevant
type 1 animal models with signature type-1 cytokine pheno-
types. These models are established by the pre-sensitization of
mice with either Mycobacterium species (BCG) or Schistosoma
mansoni antigen followed by a pulmonary challenge with sized
Sepharose beads coated with a known amount of tuberculin puri-
fied protein derivative (PPD) (Chensue et al., 1995; Ito et al., 2007,
2009a).We have also established a clinically relevant experimental
type 2 model of inflammatory granuloma development by deliv-
ering Schistosoma mansoni eggs to the lungs, which release highly
antigenic glycoproteins, referred to as Schistosoma egg antigen
(SEA), that promote a dominant Th2 response (Chensue et al.,
1992; Ruth et al., 2000; Ito et al., 2009b) (Figure 1). Schistosoma
mansoni affects more than 80 million people worldwide, caus-
ing the disease intestinal schistosomiasis (Crompton, 1999; Hotez
et al., 2008). It is the most widespread of the human-infecting
schistosomes, and the host immune response to S. mansoni
infection has been the most widely studied of the major schis-
tosome species (Pearce and Macdonald, 2002; Schramm and
Haas, 2010). These data offer the basis for continued stud-
ies to understand the mechanisms underlying these widespread
diseases.
INNATE AND ACQUIRED IMMUNITY IN GRANULOMA
DEVELOPMENT
The typical granuloma contains mostly macrophages and DCs,
surrounded by T lymphocytes, while myeloid DCs also have been
found in the granulomas of tuberculosis patients and mouse
tuberculin models (Ulrichs and Kaufmann, 2006; Ito et al., 2007;
Silva Miranda et al., 2012). Of these cells, macrophages are
the dominant cell type found in granulomas (Pieters, 2008),
and these can be of two varieties: classically activated (M1)
macrophages and alternatively activated (M2) macrophages, each
FIGURE 1 | Summary of Hematoxylin-and-eosin–stained sections showing the progression of type 1 and type 2 granuloma and the kinetic
assessment of cytokine and cellular components.
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of which have characteristic gene-expression profiles defined by
markers linked to the stimulation conditions used to gener-
ate the subtype (Gordon and Taylor, 2005; Mantovani et al.,
2007). Bacterial infection drives TLR engagement and IFN-γ
expression skewing toward the M1 macrophage phenotype
(pro-inflammatory and initiamicrobicidal), while Schistosoma
mansoni infection drives IL-4 and IL-13 skewing toward the
M2 macrophage phenotype (immunosuppressant and tissue
repairers) (Herbert et al., 2004; Mosser and Edwards, 2008). In
the granuloma, the presence of both types of macrophages may
be required to maintain a balance between the pro- and anti-
inflammatory response (Pieters, 2008). Although in comparison
to macrophages, there are fewer numbers of DCs surrounding
granulomas, the DCs play a critical role in antigen presenta-
tion, and produce large amounts of MHC-II and co-stimulatory
molecules, initiating the linkage between innate and acquired
immunity, which leads to T cell differentiation and activation
(Wolf et al., 2007). T lymphocytes account for 15–50% of the
leukocytes in mouse granulomas. About 60–70% of the T cells
present are CD4+, 15–30% are CD8+ T cells, and there are
also about 2%γδ T cells (Tsai et al., 2006; Silva Miranda et al.,
2012). Of note, for example, the essential role of CD4+ T cells
in the control of mycobacterial infection has been highlighted by
many studies in knockout mice, and also in HIV patients (Ladel
et al., 1995; Ito et al., 2007, 2009a; Geldmacher et al., 2012; Silva
Miranda et al., 2012).
TLRs FOR INNATE IMMUNITY
Innate immunity is the first line of host defense directed against
invading pathogens and is designed to maintain host integrity
(Si-Tahar et al., 2009). Innate immunity is activated immedi-
ately upon infection, is not antigen-specific, has no memory
requirement, and requires large numbers of cells for pathogen
recognition (Kabelitz and Medzhitov, 2007). Only if the invad-
ing pathogen is able to escape or overwhelm the innate response is
acquired immunity activated. In some of these latter cases the host
pro-inflammatory immune response becomes excessive, leading
to pathological inflammation (Si-Tahar et al., 2009). Recent data
suggest that the innate immune response initiated by the PAMP
activation of specific TLRs can contribute mechanistically to
maintaining the intensity and chronicity of the lung pathology
associated with the developing granuloma (Ito et al., 2007, 2009b;
Raymond et al., 2007). TLRs are named after their similarity to
Toll, an essential receptor of the innate immune system against
fungal infection, first discovered in Drosophila (Lemaitre et al.,
1996). In recent years the family of mammalian TLRs expressed
on APCs, namely DCs and macrophages, has been found to be
key PRRs with central roles in the induction of the innate immune
response. The principal functions of macrophages and DCs are
phagocytosis and the elimination of microorganisms (Takeda and
Akira, 2005). These cells also possess secondary functions includ-
ing the production of cytokines, chemokines and chemotactic
lipids, which direct certain circulating cells to migrate to the
site of infection and participate in the elimination of pathogens.
DCs also play an important role in communicating with and
presenting antigens to lymphocytes, thus linking the innate and
adaptive immune responses.
Microbial products, including mycobacterium antigen, acti-
vate specific TLRs, which in turn induce specific gene tran-
scription resulting in the up-regulation and secretion of select
chemokines and cytokines (Krutzik and Modlin, 2004; Ryffel
et al., 2005; Jo et al., 2007). When activated, TLR specifi-
cally recruit adapter proteins [Myeloid differentiation factor 88
(MyD88), MyD88 adaptor-like (MAL), TIR domain-containing
adaptor-inducing IFN-β (TRIF), and TRIF-related adaptor
molecule (TRAM)], which are essential for the TLR gene tran-
scription signaling cascade (Kawai and Akira, 2010; Kumar et al.,
2011). Recent studies have provided new insights on how TLRs
are involved in the recognition of specific pathogens, and have
clarified their roles in both the innate and adaptive immune
response (Goldstein, 2004). For example, mycobacterial compo-
nents act as agonists for TLR, and mice that are deficient in
the TLR adaptor molecule, MyD88, show an impaired response
to mycobacterial antigens (Fremond et al., 2004). Although
the response to mycobacterium antigens appears dependent on
MyD88, the TLR involved has not been identified. All TLR,
except TLR3, have at least one signaling pathway dependent
on MyD88 (Kawai and Akira, 2010). The involvement of dif-
ferent TLRs, including TLR2, TLR4, TLR6, and TLR9 has
been shown to recognize mycobacterium antigens in both mice
and humans (Abel et al., 2002; Sugawara et al., 2003; Bafica
et al., 2005; Motsinger-Reif et al., 2010). Specifically, TLR9
recognizes viral and bacterial CpG-DNA motifs, which when
bound to TLR9 on macrophages and DCs, cause their activa-
tion (Jakob et al., 1998; Sparwasser et al., 1998; Hemmi et al.,
2000). Further, TLR9 plays an important role in the regulation
of the mycobacteria-induced T helper (Th) responses during
M. tuberculosis infection in vivo (Bafica et al., 2005; Ito et al.,
2007). The activation of TLR9 requires the uptake of microbes
(or synthetic CpG oligodeoxynucleotides) within endosomes, the
formation of DNA:TLR9 complexes within the endocytic vesicles,
and the subsequent acidification and maturation of the endo-
somes (Latz et al., 2004; Wagner, 2004; Yasuda et al., 2005). Some
observations support a role for TLR9 in the host response to lung
infectious pneumonia induced by a variety of microbes including
Mycobacterium tuberculosis (Bafica et al., 2005; Bhan et al., 2007;
Kleinnijenhuis et al., 2011).We will return to this point later when
we review our own recently published data.
NOTCH SYSTEM FOR ACQUIRED IMMUNITY
Pathogens such as bacteria, helminths, fungi, and viruses are
recognized by and activate APCs, which in turn activate CD4+
Th cells (Kumar et al., 2011). The Th cells drive adaptive immu-
nity and induce specific responses against the infecting microbes
(Trinchieri and Sher, 2007). It has been shown that the dif-
ferent types of APCs and their availability to display particu-
lar cytokine production profiles, pathogen recognition receptors
(PRRs), and co-stimulatory molecules are key determinants for
Th differentiation (Carballido et al., 2006).
In addition, it has been shown that Notch proteins are also
important in the induction of Th responses (Amsen et al., 2009a;
Radtke et al., 2010). Notch is a heterodimeric cell-surface receptor
family (Notch 1–4) that is involved in a broad range of differentia-
tion processes (Bray, 2006). Notch family members are composed
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of an extracellular ligand-binding domain that is non-covalently
associated with a single-pass transmembrane domain. The Notch
signaling pathway regulates many aspects of embryonic develop-
ment, as well as differentiation processes and tissue homeostasis
in multiple adult organ systems. There are two distinct families of
Notch ligands in mammals, known as the Delta-like ligands (con-
sisting of Dll1, Dll3, and Dll4) and the Jagged ligands (Jagged1
and Jagged2); both Dll and Jagged proteins trigger the canon-
ical Notch signaling pathway wherein, binding of a ligand to a
Notch receptor results in the cleavage of the receptor at a site
in the transmembrane portion (Ehebauer et al., 2006). Upon
binding by either Dll or Jagged ligands, Notch undergoes prote-
olytic cleavage catalyzed by Adam proteases and the γ-secretase
complex, leading to the translocation of the notch intracellu-
lar domain (N-ICD) into the nucleus. N-ICD interacts with the
transcriptional repressor, recombination-signal-binding protein
for immunoglobulin-kJ region (RBP-J). The N-ICD interaction
with RBP-J and also recruits Mastermind (MAML) protein. The
new transcriptional complex of N-ICD-RBP-J-MAML converts
RBP-J from a repressor to a transcriptional activator (Dallman
et al., 2003; Ehebauer et al., 2006). Regulation of Notch signal-
ing is associated with several human disorders, including cancer.
It has been well documented in cancer studies that the Notch
pathway influences stem cell maintenance, development and cell
fate, and that it also promotes cell survival, angiogenesis, and
treatment resistance in numerous cancers, making it a promising
target for cancer therapy (D’Souza et al., 2008). More recently,
it has become evident that Notch signaling plays an impor-
tant role within the hematopoietic and immune systems. In the
mature immune system, the Notch pathway has been shown
to be involved in regulating Th1, Th2, and Th17 cell lineage
choices for T cells, each of which is characterized by the produc-
tion of distinct cytokines and effector functions (Radtke et al.,
2010; Ito et al., 2012). For example, Th1 cells produce IFN-γ
and target intracellular pathogens, while Th2 cells secrete IL-4,
IL-5, and IL-13 and target helminthes (Kapsenberg, 2003; Ito
et al., 2009b). In the presence of functional MyD88, an adaptor
molecule of TLR, PAMP (derived from bacteria, viruses, or other
TLR-ligands) binding to TLR upregulates Dll1 or Dll4 on APCs,
which causes the differentiation of naïve Th cells to a Th1 phe-
notype (Maekawa et al., 2003; Amsen et al., 2004, 2009b). On the
other hand, the differentiation of naïve Th cells to a Th2 pheno-
type occurred in the absence of functional MyD88 when Jagged
was constitutively expressed on APCs (Amsen et al., 2009b). Thus
data suggest that Dll1 and Dll4 cause Th1 skewing while Jagged
causes Th2 skewing. Moreover, recent findings described IL-17-
producing Th17 cells that play an essential role in host defense via
protection against extracellular bacterial and fungus, while also
recruiting neutrophils to the site of infection (Korn et al., 2009;
Pappu et al., 2011). Neutrophils play a key role in the front-line
defence against invading pathogens by phagocytosis as well as by
recruiting other inflammatory cells (Lowe et al., 2012). Moreover,
Th17 cells not only defend against bacterial and fungus infections
but also are involved in autoimmune disease, allergic responses,
and cancer (Wilke et al., 2011). However, how Dll- and Jagged-
expressing APCs differ in their ability to induce Notch signaling
and discriminate amongst their various described functions is
unclear. More in-depth studies using mice that are deficient in
each Notch and Notch ligand protein will provide data about how
specific Notch ligands (Delta and Jagged ligands) control the dif-
ferent types of T cell responses during physiological conditions.
Validation of the in vitro data will require a number of in vivo
studies using diverse granulomatous models, including bacterial,
parasitic, and fungal, as well as autoimmune models.
MYCOBACTERIAL GRANULOMATOUS RESPONSE THOUGH
TLRs AND NOTCH ACTIVATION
While the mechanism of granuloma formation is unclear, this
distinct cellular response is considered a histologic hallmark for
a protective immune response, involving both innate and adap-
tive immunity. TLR9 is known to play a role in the regulation
of Th1 responses (Bafica et al., 2005; Huang et al., 2005); thus,
we have investigated the role of TLR9 in granuloma formation
during challenge withmycobacterium antigens and demonstrated
that mice deficient in TLR9 had increased granuloma forma-
tion with a dramatically altered cytokine phenotype. While Th1
cytokine levels of IFN-γ and IL-12 in the lungs were decreased in
TLR9−/− mice when compared to wild-type mice, Th2 cytokine
levels of IL-4, IL-5, and IL-13 were increased in these knock-
out mice (Ito et al., 2007). This response suggests that IL-12
production is TLR9-MyD88 pathway dependent. More recently,
our group showed the first analysis of cell-mediated Th17-related
pulmonary mycobacterial Ag-elicited granuloma formation in
TLR9−/− mice and defined a role for TLR9 in the induction
of both Notch ligand Dll4 and Th17 expression using both
in vivo and in vitro approaches (Ito et al., 2009a). Our studies
demonstrated that TLR9−/− mice exhibited significantly larger
granuloma formation, following an impaired Th17-like response
with decreased expression of Dll4 on DCs from TLR9−/− mice
compared with WT mice. Dll4 was the primary Notch ligand
upregulated by mycobacterial infection of DCs in WT mice.
When Dll4 was specifically blocked in vivo using anti-Dll4 Ab
during mycobacteria-induced pulmonary granuloma formation,
Th17 cellular responses were significantly inhibited and larger
granulomas were observed. Moreover, in in vitro experiments,
anti-dll4 antibody specifically blocked IL-17 production by CD4+
T cells, while overexpression of Dll4 augmented IL-17 produc-
tion by CD4+ T cells, suggesting that Dll4 plays an important
role in promoting Th17 activity during a mycobacterial chal-
lenge. In contrast, the observed histologic alterations in lung
granuloma development in TLR9−/− mice also coincided with
a significant decrease in lung myeloid DCs, which are crucial to
the differentiation of Th17 cells, as well as decreased levels of
dll4 on DCs when compared with wild-type mice. This impaired
migration of lung myeloid DCs in granuloma was attributed to
decreased production of chemokine CCL20. Chemokines consti-
tute a family of structurally related chemotactic cytokines that
direct the migration of leukocytes throughout the body under
both physiological and inflammatory conditions (Matsushima,
2000). CCL20 and its receptor CCR6 play a role in the recruitment
of immature DCs and their precursors to sites of potential anti-
gen entry (Schutyser et al., 2003). Thus, the lower expression of
CCL20 during mycobacterial challenge in either TLR9-deficient
mice or anti-dll4–treated lungs might contribute to the observed
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decreased DC numbers during pulmonary granuloma forma-
tion. In addition, Th17 cells induced in vivo in normal mice via
homeostatic proliferation express CCR6 as well as CCL20 (Hirota
et al., 2007). Our data show that lower CCL20 expression in lungs
from TLR9−/− mice and in lungs with anti-dll4 Ab is correlated
with not only impaired DC migration but also reduced numbers
of Th17 cells in lungs during mycobacteria induced pulmonary
granuloma formation (Ito et al., 2009a) (Figure 2).
FIGURE 2 | Schematic representation of the TLR9-Notch ligand (dll4)
on Mycobacterium-dependent granuloma formation. Myeloid DCs
(mDCs) play an important role in inducing the differentiation of Th17 cells
through the TLR9 effector pathway that upregulates the Notch ligand dll4.
In vivo granuloma formation induced by BCG/Mycobacterium Ag
demonstrates larger granuloma formation in TLR9-knockout mice
(TLR9−/− ) with decreased numbers of Th17 cells (CCR6+) and mDCs in
the lungs when compared with lung granulomas from WT mice. Further,
TLR9−/− mice showed an increase in IL-10 with a concomitant decrease
in Th17 cell-related cytokines (IL-17, IL-6, IL-21, IL-23, and TNF-α) and a
decrease in the levels of the chemokines CCL20 and CCL22, important for
DC migration, compared with levels in WT mice. The decreased
expression of dll4 and the perturbation of the indicated cytokine and
chemokine expression levels led to the abrogation of the Th17 phenotype
in the Anti-Dll4 Ab treated mice with the concomitant increase in
granuloma size. Accompanying these phenomena, there was a decrease in
Th17 cells and mDCs in the lungs of Anti-Dll4 Ab treated mice and an
increase in lung macrophages.
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CONCLUDING REMARKS
Our data suggest that an understanding of Dll4 regulation of Th17
responses through Notch may provide mechanistic approaches
for modifying and controlling the immune response induced by
the Th17 phenotype. Moreover, a number of studies have demon-
strated that Notch proteins are important in the induction of Th1
responses. In the presence of functional MyD88, PAMP bind-
ing to TLR up-regulates Dll4, which causes the differentiation of
naïve Th cells to a Th1 phenotype. In addition, when Dll lig-
ands are overexpressed on APCs or are cross-linked as fusion
proteins, they also promote Th1 cell differentiation (Maekawa
et al., 2003). Our recent study also revealed that Dll1 expression
onmacrophages is dependent on type-I IFN pathways, and is crit-
ical for protection against influenza virus A (H1N1) infection (Ito
et al., 2011). Further, another of our recent findings indicated that
Notch ligand Dll4 caused an increase in the expansion of Th2
memory cells and a decrease in effector cell proliferation in our
experimental type 2 model of inflammatory granuloma develop-
ment via the embolization of Schistosoma mansoni eggs to the
lungs (Schaller et al., 2010). This study suggests that the Notch
pathway also contributes to the different responses of memory
and T effector (Teff) cells to Notch ligands, it also has been
well established that Notch ligands can have different effects on
T cell differentiation, depending on the immune environment
including the local cytokine environment. However, the Notch
system may be an even more complicated system, as these sig-
naling pathways also contribute to multiple lineage decisions of
developing lymphoid and myeloid cells. Moreover, the cellular
constituents of the lung immune system are diverse and include
not only leukocytes, such as macrophages, DCs, neutrophils, mast
cells, and lymphocytes, but also, it has been shown that epithelial
cells and fibroblasts play critical roles in the lung defense sys-
tem. Further knowledge of the regulation of the Notch system in
these cells and understanding the contextual interactions between
these populations may provide mechanistic approaches for mod-
ifying and controlling the immune response during granuloma-
tous diseases in clinically relevant translational studies. A better
understanding of the regulation of the Notch system might
contribute novel therapeutic approaches for granulomatous
diseases.
ACKNOWLEDGMENTS
We apologize to authors whose work could not be referenced
in this review due to space limitations. This work was sup-
ported by NIH (National Institutes of Health) grants HL31237,
HL89216, and JSPS (Japan Society for the Promotion of Science)
International Training Program.We also thank Robin Kunkel and
Yuki Nakashima for their artistic work.
REFERENCES
Abel, B., Thieblemont, N., Quesniaux,
V. J., Brown, N., Mpagi, J., Miyake,
K., et al. (2002). Toll-like receptor
4 expression is required to control
chronic Mycobacterium tuberculosis
infection in mice. J. Immunol. 169,
3155–3162.
Akira, S., Uematsu, S., and Takeuchi, O.
(2006). Pathogen recognition and
innate immunity.Cell 124, 783–801.
Amsen, D., Antov, A., and Flavell, R.
A. (2009a). The different faces of
Notch in T-helper-cell differentia-
tion.Nat. Rev. Immunol. 9, 116–124.
Amsen, D., Spilianakis, C. G., and
Flavell, R. A. (2009b). How are
T(H)1 and T(H)2 effector cells
made? Curr. Opin. Immunol. 21,
153–160.
Amsen, D., Blander, J. M., Lee, G. R.,
Tanigaki, K., Honjo, T., and Flavell,
R. A. (2004). Instruction of distinct
CD4 T helper cell fates by different
notch ligands on antigen-presenting
cells. Cell 117, 515–526.
Bafica, A., Scanga, C. A., Feng, C.
G., Leifer, C., Cheever, A., and
Sher, A. (2005). TLR9 regulates
Th1 responses and cooperates with
TLR2 in mediating optimal resis-
tance toMycobacterium tuberculosis.
J. Exp. Med. 202, 1715–1724.
Bhan, U., Lukacs, N. W., Osterholzer,
J. J., Newstead, M. W., Zeng,
X., Moore, T. A., et al. (2007).
TLR9 is required for protective
innate immunity in Gram-negative
bacterial pneumonia: role of
dendritic cells. J. Immunol. 179,
3937–3946.
Bray, S. J. (2006). Notch signalling: a
simple pathway becomes complex.
Nat. Rev. Mol. Cell Biol. 7, 678–689.
Carballido, J. M., Carballido-
Perrig, N., Schwarzler, C., and
Lametschwandtner, G. (2006).
Regulation of human T helper
cell differentiation by antigen-
presenting cells: the bee venom
phospholipase A2 model. Chem.
Immunol. Allergy 91, 147–158.
Carson, W. F. T., Ito, T., Schaller,
M., Cavassani, K. A., Chensue,
S. W., and Kunkel, S. L. (2011).
Dysregulated cytokine expression
by CD4+ T cells from post-septic
mice modulates both Th1 and
Th2-mediated granulomatous lung
inflammation. PLoS ONE 6:e20385.
doi: 10.1371/journal.pone.0020385
Chensue, S. W., Ruth, J. H.,
Warmington, K., Lincoln, P.,
and Kunkel, S. L. (1995). In vivo
regulation of macrophage IL-12
production during type 1 and
type 2 cytokine-mediated granu-
loma formation. J. Immunol. 155,
3546–3551.
Chensue, S. W., Terebuh, P. D.,
Warmington, K. S., Hershey, S.
D., Evanoff, H. L., Kunkel, S.
L., et al. (1992). Role of IL-4
and IFN-gamma in Schistosoma
mansoni egg-induced hypersen-
sitivity granuloma formation.
Orchestration, relative con-
tribution, and relationship to
macrophage function. J. Immunol.
148, 900–906.
Chensue, S. W., Warmington, K.,
Ruth, J., Lincoln, P., Kuo, M. C.,
and Kunkel, S. L. (1994). Cytokine
responses during mycobacterial
and schistosomal antigen-induced
pulmonary granuloma forma-
tion. Production of Th1 and Th2
cytokines and relative contribution
of tumor necrosis factor. Am.
J. Pathol. 145, 1105–1113.
Chiu, B. C., Freeman, C. M., Stolberg,
V. R., Hu, J. S., Komuniecki, E., and
Chensue, S. W. (2004). The innate
pulmonary granuloma: characteri-
zation and demonstration of den-
dritic cell recruitment and function.
Am. J. Pathol. 164, 1021–1030.
Crompton, D. W. (1999). How much
human helminthiasis is there in the
world? J. Parasitol. 85, 397–403.
Cuddapah, S., Barski, A., and Zhao, K.
(2010). Epigenomics of T cell activa-
tion, differentiation, and memory.
Curr. Opin. Immunol. 22, 341–347.
Dallman, M. J., Champion, B., and
Lamb, J. R. (2003). Notch sig-
nalling in the peripheral immune
system. Novartis Found. Symp. 252,
268–276. discussion: 276–278.
D’Souza, B., Miyamoto, A., and
Weinmaster, G. (2008). The many
facets of Notch ligands. Oncogene
27, 5148–5167.
Ehebauer, M., Hayward, P., and Arias,
A. M. (2006). Notch, a universal
arbiter of cell fate decisions. Science
314, 1414–1415.
El-Zammar, O. A., and Katzenstein,
A. L. (2007). Pathological diag-
nosis of granulomatous lung dis-
ease: a review. Histopathology 50,
289–310.
Fremond, C. M., Yeremeev, V., Nicolle,
D. M., Jacobs, M., Quesniaux,
V. F., and Ryffel, B. (2004). Fatal
Mycobacterium tuberculosis infec-
tion despite adaptive immune
response in the absence of MyD88.
J. Clin. Invest. 114, 1790–1799.
Geldmacher, C., Zumla, A., and
Hoelscher, M. (2012). Interaction
between HIV and Mycobacterium
tuberculosis: HIV-1-induced CD4
T-cell depletion and the develop-
ment of active tuberculosis. Curr.
Opin. HIV AIDS 7, 268–275.
Goldstein, D. R. (2004). Toll-like recep-
tors and other links between innate
and acquired alloimmunity. Curr.
Opin. Immunol. 16, 538–544.
Goodman, A. G., Zeng, H., Proll, S. C.,
Peng, X., Cilloniz, C., Carter, V. S.,
et al. (2010). The alpha/beta inter-
feron receptor provides protection
against influenza virus replication
but is dispensable for inflamma-
tory response signaling. J. Virol. 84,
2027–2037.
Frontiers in Immunology | Inflammation January 2013 | Volume 4 | Article 10 | 6
Ito et al. Notch system in granuloma formation
Gordon, S., and Taylor, P. R. (2005).
Monocyte and macrophage het-
erogeneity. Nat. Rev. Immunol. 5,
953–964.
Guillot, L., Le Goffic, R., Bloch, S.,
Escriou, N., Akira, S., Chignard, M.,
et al. (2005). Involvement of toll-like
receptor 3 in the immune response
of lung epithelial cells to double-
stranded RNA and influenza A
virus. J. Biol. Chem. 280, 5571–5580.
Hemmi, H., Takeuchi, O., Kawai, T.,
Kaisho, T., Sato, S., Sanjo, H., et al.
(2000). A Toll-like receptor recog-
nizes bacterial DNA. Nature 408,
740–745.
Herbert, D. R., Holscher, C., Mohrs,
M., Arendse, B., Schwegmann,
A., Radwanska, M., et al. (2004).
Alternative macrophage activation
is essential for survival during
schistosomiasis and downmod-
ulates T helper 1 responses and
immunopathology. Immunity 20,
623–635.
Hirota, K., Yoshitomi, H., Hashimoto,
M., Maeda, S., Teradaira, S.,
Sugimoto, N., et al. (2007).
Preferential recruitment of CCR6-
expressing Th17 cells to inflamed
joints via CCL20 in rheumatoid
arthritis and its animal model.
J. Exp. Med. 204, 2803–2812.
Hotez, P. J., Brindley, P. J., Bethony,
J. M., King, C. H., Pearce, E. J.,
and Jacobson, J. (2008). Helminth
infections: the great neglected trop-
ical diseases. J. Clin. Invest. 118,
1311–1321.
Huang, L. Y., Ishii, K. J., Akira,
S., Aliberti, J., and Golding, B.
(2005). Th1-like cytokine induction
by heat-killed Brucella abortus is
dependent on triggering of TLR9.
J. Immunol. 175, 3964–3970.
Ito, T., Allen, R. M., Carson, W.
F., Schaller, M., Cavassani, K. A.,
Hogaboam, C. M., et al. (2011).
The critical role of Notch lig-
and delta-like 1 in the pathogen-
esis of influenza A virus (H1N1)
Infection. PLoS Pathog. 7:e1002341.
doi: 10.1371/journal.ppat.1002341
Ito, T., Connett, J. M., Kunkel, S. L.,
and Matsukawa, A. (2012). Notch
system in the linkage of innate and
adaptive immunity. J. Leukoc. Biol.
92, 59–65.
Ito, T., Schaller, M., Hogaboam, C.
M., Standiford, T. J., Chensue, S.
W., and Kunkel, S. L. (2007). TLR9
activation is a key event for the
maintenance of a mycobacterial
antigen-elicited pulmonary granu-
lomatous response. Eur. J. Immunol.
37, 2847–2855.
Ito, T., Schaller, M., Hogaboam, C.
M., Standiford, T. J., Sandor, M.,
Lukacs, N. W., et al. (2009a). TLR9
regulates the mycobacteria-elicited
pulmonary granulomatous immune
response in mice through DC-
derived Notch ligand delta-like 4.
J. Clin. Invest. 119, 33–46.
Ito, T., Schaller, M., Raymond, T., Joshi,
A. D., Coelho, A. L., Frantz, F. G.,
et al. (2009b). Toll-like receptor 9
activation is a key mechanism for
the maintenance of chronic lung
inflammation. Am. J. Respir. Crit.
Care Med. 180, 1227–1238.
Jakob, T., Walker, P. S., Krieg, A.
M., Udey, M. C., and Vogel, J.
C. (1998). Activation of cutaneous
dendritic cells by CpG-containing
oligodeoxynucleotides: a role for
dendritic cells in the augmenta-
tion of Th1 responses by immunos-
timulatory DNA. J. Immunol. 161,
3042–3049.
Jo, E. K., Yang, C. S., Choi, C. H., and
Harding, C. V. (2007). Intracellular
signalling cascades regulating innate
immune responses to Mycobacteria:
branching out from Toll-like recep-
tors. Cell. Microbiol. 9, 1087–1098.
Joshi, A. D., Raymond, T., Coelho, A. L.,
Kunkel, S. L., and Hogaboam, C. M.
(2008). A systemic granulomatous
response to Schistosoma mansoni
eggs alters responsiveness of bone
marrow-derived macrophages to
Toll-like receptor agonists. J. Leukoc.
Biol. 83, 314–324.
Kabelitz, D., and Medzhitov, R. (2007).
Innate immunity–cross-talk with
adaptive immunity through pattern
recognition receptors and cytokines.
Curr. Opin. Immunol. 19, 1–3.
Kapsenberg, M. L. (2003). Dendritic-
cell control of pathogen-driven T-
cell polarization.Nat. Rev. Immunol.
3, 984–993.
Kawai, T., and Akira, S. (2010). The role
of pattern-recognition receptors in
innate immunity: update on Toll-
like receptors. Nat. Immunol. 11,
373–384.
Kleinnijenhuis, J., Oosting, M., Joosten,
L. A., Netea, M. G., and Van Crevel,
R. (2011). Innate immune recogni-
tion of Mycobacterium tuberculosis.
Clin. Dev. Immunol. 2011:405310.
doi: 10.1155/2011/405310
Korn, T., Bettelli, E., Oukka, M., and
Kuchroo, V. K. (2009). IL-17 and
Th17 Cells. Annu. Rev. Immunol. 27,
485–517.
Krutzik, S. R., and Modlin, R. L.
(2004). The role of Toll-like recep-
tors in combating mycobacteria.
Semin. Immunol. 16, 35–41.
Kumar, H., Kawai, T., and Akira, S.
(2009). Pathogen recognition in the
innate immune response. Biochem.
J. 420, 1–16.
Kumar, H., Kawai, T., and Akira, S.
(2011). Pathogen recognition by the
innate immune system. Int. Rev.
Immunol. 30, 16–34.
Ladel, C. H., Daugelat, S., and
Kaufmann, S. H. (1995). Immune
response to Mycobacterium bovis
bacille Calmette Guerin infection in
major histocompatibility complex
class I- and II-deficient knock-out
mice: contribution of CD4 and CD8
T cells to acquired resistance. Eur.
J. Immunol. 25, 377–384.
Latz, E., Schoenemeyer, A., Visintin,
A., Fitzgerald, K. A., Monks, B. G.,
Knetter, C. F., et al. (2004). TLR9
signals after translocating from the
ER to CpG DNA in the lysosome.
Nat. Immunol. 5, 190–198.
Lemaitre, B., Nicolas, E., Michaut, L.,
Reichhart, J. M., and Hoffmann,
J. A. (1996). The dorsoventral
regulatory gene cassette spat-
zle/Toll/cactus controls the potent
antifungal response in Drosophila
adults. Cell 86, 973–983.
Lowe, D. M., Redford, P. S., Wilkinson,
R. J., O’Garra, A., and Martineau, A.
R. (2012). Neutrophils in tuberculo-
sis: friend or foe? Trends Immunol.
33, 14–25.
Lukacs, N. W., Smit, J. J., Schaller,
M. A., and Lindell, D. M. (2008).
Regulation of immunity to respi-
ratory syncytial virus by dendritic
cells, toll-like receptors, and notch.
Viral Immunol. 21, 115–122.
Maekawa, Y., Tsukumo, S., Chiba, S.,
Hirai, H., Hayashi, Y., Okada, H.,
et al. (2003). Delta1-Notch3 inter-
actions bias the functional differen-
tiation of activated CD4+ T cells.
Immunity 19, 549–559.
Mantovani, A., Sica, A., and Locati, M.
(2007). New vistas on macrophage
differentiation and activation. Eur.
J. Immunol. 37, 14–16.
Matsushima, K. (2000). Chemokines.
Introduction. Springer Semin.
Immunopathol. 22, 321–328.
Mosser, D. M., and Edwards, J. P.
(2008). Exploring the full spectrum
of macrophage activation. Nat. Rev.
Immunol. 8, 958–969.
Motsinger-Reif, A. A., Antas, P. R.,
Oki, N. O., Levy, S., Holland, S.
M., and Sterling, T. R. (2010).
Polymorphisms in IL-1beta, vita-
min D receptor Fok1, and Toll-like
receptor 2 are associated with extra-
pulmonary tuberculosis. BMC Med.
Genet. 11:37. doi: 10.1186/1471-
2350-11-37
Osborne, B. A., and Minter, L. M.
(2007). Notch signalling during
peripheral T-cell activation and dif-
ferentiation. Nat. Rev. Immunol. 7,
64–75.
Pappu, R., Ramirez-Carrozzi, V.,
and Sambandam, A. (2011). The
interleukin-17 cytokine family:
critical players in host defence and
inflammatory diseases. Immunology
134, 8–16.
Pearce, E. J., and Macdonald, A. S.
(2002). The immunobiology of
schistosomiasis. Nat. Rev. Immunol.
2, 499–511.
Pieters, J. (2008). Mycobacterium tuber-
culosis and the macrophage: main-
taining a balance. Cell Host Microbe
3, 399–407.
Radtke, F., Fasnacht, N., and
Macdonald, H. R. (2010). Notch
signaling in the immune system.
Immunity 32, 14–27.
Ramakrishnan, L. (2012). Revisiting
the role of the granuloma in tuber-
culosis. Nat. Rev. Immunol. 12,
352–366.
Raymond, T., Schaller, M., Hogaboam,
C. M., Lukacs, N. W., Rochford,
R., and Kunkel, S. L. (2007).
Toll-like receptors, Notch ligands,
and cytokines drive the chronicity
of lung inflammation. Proc. Am.
Thorac. Soc. 4, 635–641.
Ruth, J. H., Warmington, K. S., Shang,
X., Lincoln, P., Evanoff, H., Kunkel,
S. L., et al. (2000). Interleukin 4 and
13 participation in mycobacterial
(type-1) and schistosomal (type-2)
antigen-elicited pulmonary gran-
uloma formation: multiparameter
analysis of cellular recruitment,
chemokine expression and cytokine
networks. Cytokine 12, 432–444.
Ryffel, B., Fremond, C., Jacobs, M.,
Parida, S., Botha, T., Schnyder, B.,
et al. (2005). Innate immunity to
mycobacterial infection in mice:
critical role for toll-like receptors.
Tuberculosis (Edinb.) 85, 395–405.
Schaller, M. A., Logue, H., Mukherjee,
S., Lindell, D. M., Coelho, A. L.,
Lincoln, P., et al. (2010). Delta-Like
4 differentially regulates murine
CD4(+) T cell expansion via
BMI1. PLoS ONE 5:e12172. doi:
10.1371/journal.pone.0012172
Schramm, G., and Haas, H. (2010).
Th2 immune response against
Schistosoma mansoni infection.
Microbes Infect. 12, 881–888.
Schutyser, E., Struyf, S., and Van
Damme, J. (2003). The CC
chemokine CCL20 and its receptor
CCR6. Cytokine Growth Factor Rev.
14, 409–426.
Silva Miranda, M., Breiman, A., Allain,
S., Deknuydt, F., and Altare, F.
(2012). The tuberculous granu-
loma: an unsuccessful host defence
mechanism providing a safety
shelter for the bacteria? Clin.
Dev. Immunol. 2012:139127. doi:
10.1155/2012/139127
Si-Tahar, M., Touqui, L., and Chignard,
M. (2009). Innate immunity and
inflammation–two facets of the
www.frontiersin.org January 2013 | Volume 4 | Article 10 | 7
Ito et al. Notch system in granuloma formation
same anti-infectious reaction. Clin.
Exp. Immunol. 156, 194–198.
Sparwasser, T., Koch, E. S., Vabulas,
R. M., Heeg, K., Lipford, G. B.,
Ellwart, J. W., et al. (1998). Bacterial
DNA and immunostimulatory CpG
oligonucleotides trigger maturation
and activation of murine den-
dritic cells. Eur. J. Immunol. 28,
2045–2054.
Sugawara, I., Yamada, H., Li, C.,
Mizuno, S., Takeuchi, O., and Akira,
S. (2003). Mycobacterial infection
in TLR2 and TLR6 knockout mice.
Microbiol. Immunol. 47, 327–336.
Takeda, K., and Akira, S. (2005). Toll-
like receptors in innate immunity.
Int. Immunol. 17, 1–14.
Trinchieri, G., and Sher, A. (2007).
Cooperation of Toll-like receptor
signals in innate immune defence.
Nat. Rev. Immunol. 7, 179–190.
Tsai, M. C., Chakravarty, S., Zhu,
G., Xu, J., Tanaka, K., Koch, C.,
et al. (2006). Characterization of the
tuberculous granuloma in murine
and human lungs: cellular composi-
tion and relative tissue oxygen ten-
sion. Cell. Microbiol. 8, 218–232.
Ulrichs, T., and Kaufmann, S. H.
(2006). New insights into the func-
tion of granulomas in human tuber-
culosis. J. Pathol. 208, 261–269.
Wagner, H. (2004). The immunobiol-
ogy of the TLR9 subfamily. Trends
Immunol. 25, 381–386.
Warren, K. S. (1976). A functional clas-
sification of granulomatous inflam-
mation. Ann. N.Y. Acad. Sci. 278,
7–18.
Wilke, C. M., Bishop, K., Fox, D., and
Zou, W. (2011). Deciphering the
role of Th17 cells in human disease.
Trends Immunol. 32, 603–611.
Wolf, A. J., Linas, B., Trevejo-Nunez, G.
J., Kincaid, E., Tamura, T., Takatsu,
K., et al. (2007). Mycobacterium
tuberculosis infects dendritic cells
with high frequency and impairs
their function in vivo. J. Immunol.
179, 2509–2519.
Yasuda, K., Ogawa, Y., Yamane, I.,
Nishikawa, M., and Takakura, Y.
(2005). Macrophage activation by
a DNA/cationic liposome complex
requires endosomal acidifica-
tion and TLR9-dependent and
-independent pathways. J. Leukoc.
Biol. 77, 71–79.
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 03 November 2012; accepted:
07 January 2013; published online: 31
January 2013.
Citation: Ito T, Connett JM, Kunkel SL
and Matsukawa A (2013) The link-
age of innate and adaptive immune
response during granulomatous develop-
ment. Front. Immun. 4:10. doi: 10.3389/
fimmu.2013.00010
This article was submitted to Frontiers in
Inflammation, a specialty of Frontiers in
Immunology.
Copyright © 2013 Ito, Connett, Kunkel
and Matsukawa. This is an open-
access article distributed under the terms
of the Creative Commons Attribution
License, which permits use, distribution
and reproduction in other forums, pro-
vided the original authors and source
are credited and subject to any copy-
right notices concerning any third-party
graphics etc.
Frontiers in Immunology | Inflammation January 2013 | Volume 4 | Article 10 | 8
